Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ISB 1442 / Glenmark
ACTRN12622000856718: A First-in-Human Study of Single-Agent ISB 1442 in Patients with Relapsed/Refractory Multiple Myeloma	Not yet recruiting	1/2	121			Ichnos Sciences SA, Ichnos Sciences SA	Relapsed Multiple Myeloma, Refractory Multiple Myeloma
NCT05427812: Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma	Recruiting	1/2	121	US, RoW	ISB 1442 SC injection escalating doses, ISB 1442 SC injection at RP2D	Ichnos Sciences SA	Relapsed/Refractory Multiple Myeloma	05/27	05/27